![Gilmore O’Neill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gilmore O’Neill
Amministratore Delegato presso
EDITAS MEDICINE, INC.
Patrimonio netto: 859 163 $ in data 31/05/2026
Profilo
Gilmore ONeill occupa la posizione di Chief Medical Officer & Executive Vice President presso Sarepta Therapeutics, Inc. Il Dr. ONeill è anche nel consiglio del Massachusetts Biotechnology Council e della Unity Biotechnology, Inc. e membro dell'American Academy of Neurology. Nella sua carriera passata ha ricoperto la posizione di vicepresidente senior per Biogen, Inc. Gilmore ONeill si è laureato all'University College di Dublino e si è laureato alla Harvard University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2026 | 248.313 ( 0,16% ) | 859 163 $ | 31/05/2026 |
Posizioni attive di Gilmore O’Neill
| Società | Posizione | Inizio |
|---|---|---|
| EDITAS MEDICINE, INC. | Amministratore Delegato | 01/06/2022 |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Gilmore O’Neill
| Società | Posizione | Fine |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Direttore/Membro del Consiglio | 27/06/2025 |
| APTINYX | Direttore/Membro del Consiglio | 14/04/2023 |
| SAREPTA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 17/11/2021 |
| BIOGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2018 |
| APTINYX | Direttore/Membro del Consiglio | - |
Formazione di Gilmore O’Neill
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
